LEGN
Legend Biotech Corporation
NASDAQ · Healthcare · Biotechnology · US
$21.57
−0.83%Leverage
- Debt / equity
- 0.23x
- Net debt / equity
- -0.32x
- Debt / assets
- 0.16x
- Debt / EBITDA
- -38.41x
- Net debt / EBITDA
- 54.49x
Liquidity & coverage
- Current ratio
- 3.04x
- Quick ratio
- 2.94x
- Cash ratio
- 2.39x
- Interest coverage
- -3.34x
- EBITDA / interest
- -0.43x
- Working capital
- $823.8M
Cash & dividend
- FCF / debt
- -0.92x
- Cash flow / debt
- -0.66x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026